These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 3567923)
1. Effect of verapamil on in vitro cytotoxicity of adriamycin and vinblastine in human tumor cells. Goodman GE; Yen YP; Cox TC; Crowley J Cancer Res; 1987 May; 47(9):2295-304. PubMed ID: 3567923 [TBL] [Abstract][Full Text] [Related]
2. Establishment and serial quantification of intrahepatic xenografts of human hepatocellular carcinoma in severe combined immunodeficiency mice, and development of therapeutic strategies to overcome multidrug resistance. Leveille-Webster CR; Arias IA Clin Cancer Res; 1996 Apr; 2(4):695-706. PubMed ID: 9816220 [TBL] [Abstract][Full Text] [Related]
3. Resistance to adriamycin: relationship of cytotoxicity to drug uptake and DNA single- and double-strand breakage in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia. Goldenberg GJ; Wang H; Blair GW Cancer Res; 1986 Jun; 46(6):2978-83. PubMed ID: 3698020 [TBL] [Abstract][Full Text] [Related]
4. [Reversal of adriamycin resistance by verapamil and ligustrazini in mouse Ehrlich ascites cancer]. Hu YP; Lin J; Wang QD; Yie QX; Zhang TM Yao Xue Xue Bao; 1993; 28(1):75-8. PubMed ID: 8328276 [TBL] [Abstract][Full Text] [Related]
5. DNA breakage, cytotoxicity, drug accumulation and retention in two human ovarian tumor cell lines AZ224 and AZ364 treated with adriamycin, modulated by verapamil. Delvaeye M; Verovski V; De Neve W; Storme G Anticancer Res; 1993; 13(5A):1533-8. PubMed ID: 8239532 [TBL] [Abstract][Full Text] [Related]
6. Promotion by verapamil of vincristine responsiveness in tumor cell lines inherently resistant to the drug. Tsuruo T; Iida H; Naganuma K; Tsukagoshi S; Sakurai Y Cancer Res; 1983 Feb; 43(2):808-13. PubMed ID: 6848194 [TBL] [Abstract][Full Text] [Related]
7. Enhancement of sensitivity to adriamycin in resistant P388 leukemia by the calmodulin inhibitor trifluoperazine. Ganapathi R; Grabowski D Cancer Res; 1983 Aug; 43(8):3696-9. PubMed ID: 6861140 [TBL] [Abstract][Full Text] [Related]
8. Enhancement of Fas-mediated apoptosis in renal cell carcinoma cells by adriamycin. Wu XX; Mizutani Y; Kakehi Y; Yoshida O; Ogawa O Cancer Res; 2000 Jun; 60(11):2912-8. PubMed ID: 10850437 [TBL] [Abstract][Full Text] [Related]
9. A novel taxane with improved tolerability and therapeutic activity in a panel of human tumor xenografts. Polizzi D; Pratesi G; Tortoreto M; Supino R; Riva A; Bombardelli E; Zunino F Cancer Res; 1999 Mar; 59(5):1036-40. PubMed ID: 10070960 [TBL] [Abstract][Full Text] [Related]
10. A comparison of the modulation of antiblastics cytotoxicity by verapamil and dipyridamole in a human colon carcinoma cell line. Berti E; Carrara M; Ragazzi E; D'Ancona S; Berti T Int J Oncol; 1999 Jul; 15(1):155-60. PubMed ID: 10375609 [TBL] [Abstract][Full Text] [Related]
11. Possible link between the intrinsic drug resistance of colon tumors and a detoxification mechanism of intestinal cells. Klohs WD; Steinkampf RW Cancer Res; 1988 Jun; 48(11):3025-30. PubMed ID: 3365692 [TBL] [Abstract][Full Text] [Related]
12. Verapamil-mediated sensitization of doxorubicin-selected pleiotropic resistance in human sarcoma cells: selectivity for drugs which produce DNA scission. Harker WG; Bauer D; Etiz BB; Newman RA; Sikic BI Cancer Res; 1986 May; 46(5):2369-73. PubMed ID: 3754487 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic profile of the microtubule stabilizer patupilone in tumor-bearing rodents and comparison of anti-cancer activity with other MTS in vitro and in vivo. O'Reilly T; Wartmann M; Brueggen J; Allegrini PR; Floersheimer A; Maira M; McSheehy PM Cancer Chemother Pharmacol; 2008 Nov; 62(6):1045-54. PubMed ID: 18301895 [TBL] [Abstract][Full Text] [Related]
14. Antitumor activity of the new vinca-alkaloid S 12363 alone or in combination with verapamil on a human multidrug resistant renal carcinoma xenograft. Berlion M; Arvelo F; Leonce S; Bourgeois Y; Rigaudy P; Bizzari JP; Poupon MF In Vivo; 1993; 7(5):399-405. PubMed ID: 7906553 [TBL] [Abstract][Full Text] [Related]
15. Modulation of vindesine and doxorubicin resistance in multidrug-resistant pleural mesothelioma cells by tumor necrosis factor-alpha. Licht T; Lübbert M; Martens C; Bross KJ; Fiebig HH; Mertelsmann R; Herrmann F Cytokines Mol Ther; 1995 Jun; 1(2):123-32. PubMed ID: 9384669 [TBL] [Abstract][Full Text] [Related]
16. [Relationship between multidrug resistance in human colon carcinoma LoVo/Adr cell line and intracellular calcium ion concentration]. Ma Q; Zhang ZS; Zhang YL; Lai ZS Ai Zheng; 2002 Aug; 21(8):846-9. PubMed ID: 12478890 [TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms of loss of beta 2-microglobulin expression in drug-resistant breast cancer sublines and its involvement in drug resistance. Ogretmen B; McCauley MD; Safa AR Biochemistry; 1998 Aug; 37(33):11679-91. PubMed ID: 9709006 [TBL] [Abstract][Full Text] [Related]
18. Transferrin directed delivery of adriamycin to human cells. Singh M; Atwal H; Micetich R Anticancer Res; 1998; 18(3A):1423-7. PubMed ID: 9673350 [TBL] [Abstract][Full Text] [Related]
19. [A comparative study on effect of two bisbenzylisoquinolines, tetrandrine and berbamine, on reversal of multidrug resistance]. Tian H; Pan QC Yao Xue Xue Bao; 1997 Apr; 32(4):245-50. PubMed ID: 11499024 [TBL] [Abstract][Full Text] [Related]
20. Reversal of acquired resistance to doxorubicin in P388 murine leukemia cells by perhexiline maleate. Ramu A; Fuks Z; Gatt S; Glaubiger D Cancer Res; 1984 Jan; 44(1):144-8. PubMed ID: 6690032 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]